PH12017500963A1 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone - Google Patents
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodoneInfo
- Publication number
- PH12017500963A1 PH12017500963A1 PH12017500963A PH12017500963A PH12017500963A1 PH 12017500963 A1 PH12017500963 A1 PH 12017500963A1 PH 12017500963 A PH12017500963 A PH 12017500963A PH 12017500963 A PH12017500963 A PH 12017500963A PH 12017500963 A1 PH12017500963 A1 PH 12017500963A1
- Authority
- PH
- Philippines
- Prior art keywords
- oxycodone
- benzoic acid
- conjugates
- heteroaryl carboxylic
- derivatives
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title abstract 4
- 229960002085 oxycodone Drugs 0.000 title abstract 4
- -1 heteroaryl carboxylic acid Chemical class 0.000 title abstract 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 title abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 title 2
- 239000005711 Benzoic acid Substances 0.000 title 1
- 235000010233 benzoic acid Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- 229940111136 antiinflammatory and antirheumatic drug fenamates Drugs 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003873 salicylate salts Chemical class 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C07D489/04—Salts; Organic complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462084246P | 2014-11-25 | 2014-11-25 | |
| US201462084216P | 2014-11-25 | 2014-11-25 | |
| PCT/US2015/062637 WO2016086113A1 (en) | 2014-11-25 | 2015-11-25 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12017500963A1 true PH12017500963A1 (en) | 2017-10-18 |
Family
ID=56075034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12017500963A PH12017500963A1 (en) | 2014-11-25 | 2017-05-25 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9850252B2 (enExample) |
| EP (1) | EP3223819A4 (enExample) |
| JP (2) | JP6400848B2 (enExample) |
| KR (2) | KR20190049944A (enExample) |
| CN (1) | CN106999486A (enExample) |
| AU (1) | AU2015353502B2 (enExample) |
| BR (1) | BR112017011069A2 (enExample) |
| CA (1) | CA2967424C (enExample) |
| CL (1) | CL2017001353A1 (enExample) |
| CO (1) | CO2017005201A2 (enExample) |
| IL (1) | IL252470B (enExample) |
| MX (1) | MX2017006520A (enExample) |
| NZ (1) | NZ731591A (enExample) |
| PH (1) | PH12017500963A1 (enExample) |
| RU (1) | RU2683317C2 (enExample) |
| SG (1) | SG11201704178UA (enExample) |
| WO (1) | WO2016086113A1 (enExample) |
| ZA (1) | ZA201703154B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10849981B2 (en) | 2009-07-02 | 2020-12-01 | KemPham, Inc. | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| UA102916C2 (uk) | 2009-07-02 | 2013-08-27 | Кемфарм, Інк. | Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань |
| SG11201704178UA (en) | 2014-11-25 | 2017-06-29 | Kempharm Inc | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone |
| US20200038383A1 (en) * | 2016-10-14 | 2020-02-06 | Kempharm, Inc. | Immediate-release abuse deterrent compositions or medicaments for treating pain, add, adhd and other syndromes or disorders |
| EP3654977A4 (en) * | 2017-07-20 | 2021-06-09 | Suzhou Runxindatai Pharmaceutics Ltd Co. | SUSTAINABLE RELEASE, ABUSE RESISTANT OPIOID PRODRUGS |
| US11845759B2 (en) | 2018-02-23 | 2023-12-19 | Rhodes Technologies | Opioid compounds and uses thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB320749A (enExample) | ||||
| US1731152A (en) | 1925-10-27 | 1929-10-08 | Firm C H Boehringer Sohn | Process for the manufacture of derivatives of dihydrocodeinone or its substitution products |
| AT229496B (de) | 1961-03-08 | 1963-09-25 | Lannacher Heilmittel | Verfahren zur Darstellung des neuen Nicotinsäureesters des Dihydrohydroxycodeinons |
| US4668685A (en) | 1984-07-05 | 1987-05-26 | E.I. Du Pont De Nemours And Company | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists |
| SE9003665D0 (sv) | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
| GB9423542D0 (en) | 1994-11-22 | 1995-01-11 | Marples Brian A | Pharmaceutical compounds |
| US5869669A (en) | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
| WO2001054481A2 (en) | 2000-01-28 | 2001-08-02 | Rohm And Haas Company | Enhanced propertied pharmaceuticals |
| ATE506064T1 (de) | 2001-06-05 | 2011-05-15 | Control Delivery Systems | Analgetika mit verzögerter wirkstoffabgabe |
| US7375082B2 (en) | 2002-02-22 | 2008-05-20 | Shire Llc | Abuse-resistant hydrocodone compounds |
| IL163667A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Novel sustained release pharmaceutical compounds to preventabuse of controlled substances |
| US20040058946A1 (en) * | 2002-07-05 | 2004-03-25 | Buchwald Stephen L. | Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
| TW200500067A (en) | 2003-01-21 | 2005-01-01 | Control Delivery Sys Inc | Salts of codrugs and uses related thereto |
| EP1782834A3 (en) * | 2003-03-13 | 2007-08-01 | Controlled Chemicals, Inc. | Oxycodone conjugates with lower abuse potential and extended duration of action |
| ATE454169T1 (de) | 2003-03-13 | 2010-01-15 | Controlled Chemicals Inc | Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer |
| AU2004277400B2 (en) | 2003-09-30 | 2009-01-22 | Shire Llc | Pharmaceutical compositions for prevention of overdose or abuse |
| CA2874604A1 (en) * | 2003-10-03 | 2005-04-21 | Elite Laboratories Inc. | Extended release formulations of opioids and method of use thereof |
| US20050203115A1 (en) * | 2004-03-10 | 2005-09-15 | Sancilio Frederick D. | Narcotic-NSAID ion pairs |
| EP1751087B1 (en) | 2004-06-04 | 2012-06-27 | XenoPort, Inc. | Levodopa derivatives, and compositions and uses thereof |
| US7348430B2 (en) | 2005-01-21 | 2008-03-25 | Acura Pharmaceuticals, Inc. | Production of opioid analgesics |
| EP2007762A2 (en) * | 2006-04-10 | 2008-12-31 | Shire LLC | Mono and di-substituted oxycodone compounds and compositions |
| EP2402037B8 (en) | 2006-05-26 | 2019-12-04 | Signature Therapeutics, Inc. | Controlled release of phenolic opioids |
| US20080090771A1 (en) | 2006-10-06 | 2008-04-17 | Shire Llc | Abuse-resistant hydrocodone compounds, compositions and methods of using the same |
| NZ586194A (en) | 2007-12-17 | 2012-07-27 | Mallinckrodt Llc | Processes for the production of (+)-'nal' morphinan compounds |
| UA102916C2 (uk) | 2009-07-02 | 2013-08-27 | Кемфарм, Інк. | Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань |
| US8871780B2 (en) * | 2009-07-02 | 2014-10-28 | Kempharm, Inc. | Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof |
| WO2011008636A1 (en) | 2009-07-15 | 2011-01-20 | Mallinckrodt Inc. | 3-oxy-hydromorphone derivatives |
| US8569228B2 (en) * | 2011-01-11 | 2013-10-29 | Signature Therapeutics, Inc. | Compositions comprising enzyme-cleavable oxycodone prodrug |
| PH12014500791A1 (en) | 2011-10-26 | 2022-12-02 | Kempharm Inc | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof |
| SG11201704178UA (en) | 2014-11-25 | 2017-06-29 | Kempharm Inc | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone |
-
2015
- 2015-11-25 SG SG11201704178UA patent/SG11201704178UA/en unknown
- 2015-11-25 EP EP15863639.9A patent/EP3223819A4/en not_active Withdrawn
- 2015-11-25 NZ NZ731591A patent/NZ731591A/en not_active IP Right Cessation
- 2015-11-25 BR BR112017011069A patent/BR112017011069A2/pt not_active Application Discontinuation
- 2015-11-25 AU AU2015353502A patent/AU2015353502B2/en not_active Ceased
- 2015-11-25 KR KR1020197012631A patent/KR20190049944A/ko not_active Withdrawn
- 2015-11-25 RU RU2017122144A patent/RU2683317C2/ru not_active IP Right Cessation
- 2015-11-25 MX MX2017006520A patent/MX2017006520A/es unknown
- 2015-11-25 US US14/952,348 patent/US9850252B2/en active Active
- 2015-11-25 CN CN201580064309.XA patent/CN106999486A/zh active Pending
- 2015-11-25 KR KR1020177017408A patent/KR101976101B1/ko not_active Expired - Fee Related
- 2015-11-25 JP JP2017528967A patent/JP6400848B2/ja not_active Expired - Fee Related
- 2015-11-25 WO PCT/US2015/062637 patent/WO2016086113A1/en not_active Ceased
- 2015-11-25 CA CA2967424A patent/CA2967424C/en active Active
-
2017
- 2017-05-08 ZA ZA2017/03154A patent/ZA201703154B/en unknown
- 2017-05-23 IL IL252470A patent/IL252470B/en not_active IP Right Cessation
- 2017-05-25 CL CL2017001353A patent/CL2017001353A1/es unknown
- 2017-05-25 CO CONC2017/0005201A patent/CO2017005201A2/es unknown
- 2017-05-25 PH PH12017500963A patent/PH12017500963A1/en unknown
- 2017-11-14 US US15/812,730 patent/US10144740B2/en active Active
-
2018
- 2018-09-04 JP JP2018165325A patent/JP2018199719A/ja active Pending
- 2018-10-19 US US16/165,194 patent/US10544153B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CL2017001353A1 (es) | 2018-01-05 |
| US20160168160A1 (en) | 2016-06-16 |
| RU2017122144A3 (enExample) | 2018-12-26 |
| US20180065975A1 (en) | 2018-03-08 |
| CN106999486A (zh) | 2017-08-01 |
| KR20170094249A (ko) | 2017-08-17 |
| JP2017535593A (ja) | 2017-11-30 |
| CA2967424C (en) | 2023-05-02 |
| SG11201704178UA (en) | 2017-06-29 |
| EP3223819A4 (en) | 2018-04-25 |
| US10544153B2 (en) | 2020-01-28 |
| IL252470A0 (en) | 2017-07-31 |
| US20190048018A1 (en) | 2019-02-14 |
| US10144740B2 (en) | 2018-12-04 |
| US9850252B2 (en) | 2017-12-26 |
| JP2018199719A (ja) | 2018-12-20 |
| BR112017011069A2 (pt) | 2018-07-10 |
| AU2015353502A1 (en) | 2017-05-25 |
| CA2967424A1 (en) | 2016-06-02 |
| ZA201703154B (en) | 2019-03-27 |
| IL252470B (en) | 2019-08-29 |
| RU2017122144A (ru) | 2018-12-26 |
| JP6400848B2 (ja) | 2018-10-03 |
| NZ731591A (en) | 2018-06-29 |
| KR101976101B1 (ko) | 2019-05-09 |
| KR20190049944A (ko) | 2019-05-09 |
| RU2683317C2 (ru) | 2019-03-28 |
| CO2017005201A2 (es) | 2017-08-31 |
| WO2016086113A1 (en) | 2016-06-02 |
| EP3223819A1 (en) | 2017-10-04 |
| AU2015353502B2 (en) | 2018-09-27 |
| MX2017006520A (es) | 2017-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500963A1 (en) | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone | |
| MY153046A (en) | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | |
| PH12014500791A1 (en) | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| HK1244708A1 (zh) | 作爲fxr/tgr5激动剂的胆汁酸类似物及其使用方法 | |
| WO2015017821A3 (en) | Therapeutically active compounds and their methods of use | |
| NZ728162A (en) | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | |
| EA032972B1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
| GEP201706725B (en) | Compounds and compositions as inhibitors of mek | |
| WO2015104292A3 (en) | Compounds for use in treating or preventing cancerous diseases | |
| PH12017500859A1 (en) | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods and making and use thereof | |
| WO2015033228A3 (en) | Compounds and use for treating cancer | |
| BR112015029504A2 (pt) | inibidores quinase | |
| MX376029B (es) | Compuestos de isoindol. | |
| WO2016057658A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| MX374725B (es) | Composiciones farmacéuticas que comprenden derivado de fenilaminopirimidina. | |
| BR112018007673A2 (pt) | ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos? | |
| WO2016057660A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| MX2017002544A (es) | Derivados de isoquinolinona utiles en el tratamiento contra el cancer. | |
| WO2015109017A3 (en) | Deuterated no-releasing nonoate(oxygen-bound)chromene conjugates | |
| EA201792502A1 (ru) | Кабазитаксел и его применение для лечения рака | |
| MX359974B (es) | Compuestos analogos del ester fenetilico del acido cafeico y uso de los mismos para preparacion de composiciones farmaceuticas para prevencion y tratamiento de cancer. | |
| WO2015015102A3 (fr) | Nouveaux complexes d'agomelatine et d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| HK1224582A1 (en) | Therapeutically active compounds and their methods of use | |
| MY176807A (en) | Novel indazole compounds and a process for the preparation thereof |